Pfizer Inc. secured a reprieve from President Donald Trump’s long-threatened tariffs on the pharmaceutical industry Tuesday ...
Pfizer Inc. (NYSE: PFE, "Pfizer") will present data across its infectious disease portfolio at the upcoming IDWeek 2025 ...
Market Catalysts host Julie Hyman and Yahoo Finance senior reporter Brooke DiPalma track several of the day's top trending ...
Pfizer delivered strong 2Q25 results with double-digit revenue growth and margin expansion. Click here to read why PFE stock ...
Moderna and Pfizer-BioNTech are in a tight race to launch their COVID-19 vaccines in Europe after both applied for emergency EU approval on Tuesday, though there was uncertainty over whether a rollout ...
Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...
Pfizer Inc applied to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback